NASDAQ · Healthcare · Biotechnology
NewAmsterdam Pharma Company N.V.
NAMS
NewAmsterdam Pharma Company N. CEO Michael Harvey Davidson Facp. · Market cap $4.4B.
$37.46
-1.43 · -3.68%
52w hi $42.2052w lo $16.79
Off 52w high 29.2%
61
NOTABLE
Current InsiderScore
Corp · 90d
9
0 buys · 9 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
1
0 strong · 1 notable
Analyst consensus
Strong Buy
Avg PT $46.00
Section 01
Recent Form 4 filings
21 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Mar 11 | Louis G Lange | Sell | 44,173 | $30.41 | −$1.34M | 35 | |
| Mar 09 | Johannes Jacob Pieter Kastelein | Chief Scientific Officer | Sell | 101,409 | $30.29 | −$3.07M | 35 |
| Mar 06 | Johannes Jacob Pieter Kastelein | Chief Scientific Officer | Sell | 94,124 | $30.32 | −$2.85M | 35 |
| Mar 05 | Johannes Jacob Pieter Kastelein | Chief Scientific Officer | Sell | 104,467 | $30.30 | −$3.17M | 35 |
| Mar 02 | Michael H. Davidson | Chief Executive Officer | Sell | 443,707 | $33.25 | −$14.75M | 61 |
| Feb 26 | Michael H. Davidson | Chief Executive Officer | Sell | 165,408 | $33.63 | −$5.56M | 58 |
| Feb 25 | Michael H. Davidson | Chief Executive Officer | Sell | 46,517 | $35.11 | −$1.63M | 34 |
| Feb 24 | Michael H. Davidson | Chief Executive Officer | Sell | 61,547 | $36.13 | −$2.22M | 37 |
| Feb 20 | Johannes Jacob Pieter Kastelein | Chief Scientific Officer | Sell | 30,789 | $35.46 | −$1.09M | 32 |
| Jan 28 | Louise Frederika Kooij | Chief Accounting Officer | Sell | 32,612 | $31.80 | −$1.04M | 37 |
| Jan 27 | Louise Frederika Kooij | Chief Accounting Officer | Sell | 39,816 | $32.62 | −$1.30M | 37 |
| Jan 26 | Louise Frederika Kooij | Chief Accounting Officer | Sell | 34,091 | $32.77 | −$1.12M | 37 |
| Dec 26 | Louise Frederika Kooij | Chief Accounting Officer | Sell | 43,872 | $35.30 | −$1.55M | 37 |
| Dec 23 | Louise Frederika Kooij | Chief Accounting Officer | Sell | 75,117 | $36.21 | −$2.72M | 37 |
| Sep 09 | Louise Frederika Kooij | Chief Accounting Officer | Sell | 96,896 | $26.11 | −$2.53M | 37 |
| Sep 09 | Louise Frederika Kooij | Chief Accounting Officer | Sell | 53,104 | $25.31 | −$1.34M | 34 |
| Sep 08 | James N Topper | Buy | 1,260 | $24.99 | +$31K | 31 | |
| Aug 22 | Johannes Jacob Pieter Kastelein | Chief Scientific Officer | Sell | 42,342 | $25.08 | −$1.06M | 32 |
| Aug 21 | Johannes Jacob Pieter Kastelein | Chief Scientific Officer | Sell | 50,000 | $24.29 | −$1.21M | 32 |
| Jun 24 | James N Topper | Buy | 2,520 | $18.43 | +$46K | 31 | |
| Jun 16 | James N Topper | Buy | 8,584 | $19.50 | +$167K | 36 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay